Clinical Read2026-06-11

Teverelix - (PRECISION-E2)

Name: Teverelix - (PRECISION-E2)
Start: 2026-06-11

Medicus Pharma Ltd.MDCX

Indication: Hormone-driven conditions, including endometriosis and uterine fibroids, Moderate-to-severe symptomatic endometriosis
Stage: phase2
Event: Phase 2